INM, Univ Montpellier, INSERM, Montpellier, France.
Sorbonne Universités, Université Pierre et Marie Curie UM 119, Neurosciences Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Paris, France.
J Physiol. 2021 Dec;599(24):5397-5416. doi: 10.1113/JP282181. Epub 2021 Dec 1.
DFNA25 is an autosomal-dominant and progressive form of human deafness caused by mutations in the SLC17A8 gene, which encodes the vesicular glutamate transporter type 3 (VGLUT3). To resolve the mechanisms underlying DFNA25, we studied phenotypes of mice harbouring the p.A221V mutation in humans (corresponding to p.A224V in mice). Using auditory brainstem response and distortion product otoacoustic emissions, we showed progressive hearing loss with intact cochlear amplification in the VGLUT3 mouse. The summating potential was reduced, indicating the alteration of inner hair cell (IHC) receptor potential. Scanning electron microscopy examinations demonstrated the collapse of stereocilia bundles in IHCs, leaving those from outer hair cells unaffected. In addition, IHC ribbon synapses underwent structural and functional modifications at later stages. Using super-resolution microscopy, we observed oversized synaptic ribbons and patch-clamp membrane capacitance measurements showed an increase in the rate of the sustained releasable pool exocytosis. These results suggest that DFNA25 stems from a failure in the mechano-transduction followed by a change in synaptic transfer. The VGLUT3 mouse model opens the way to a deeper understanding and to a potential treatment for DFNA25. KEY POINTS: The vesicular glutamate transporter type 3 (VGLUT3) loads glutamate into the synaptic vesicles of auditory sensory cells, the inner hair cells (IHCs). The VGLUT3-p.A211V variant is associated with human deafness DFNA25. Mutant mice carrying the VGLUT3-p.A211V variant show progressive hearing loss. IHCs from mutant mice harbour distorted stereocilary bundles, which detect incoming sound stimulation, followed by oversized synaptic ribbons, which release glutamate onto the afferent nerve fibres. These results suggest that DFNA25 stems from the failure of auditory sensory cells to faithfully transduce acoustic cues into neural messages.
DFNA25 是一种常染色体显性遗传性渐进性听力损失疾病,由 SLC17A8 基因突变引起,该基因编码囊泡谷氨酸转运体 3(VGLUT3)。为了阐明 DFNA25 的发病机制,我们研究了携带人类 p.A221V 突变(对应于小鼠中的 p.A224V)的小鼠表型。通过听觉脑干反应和畸变产物耳声发射,我们发现 VGLUT3 小鼠的听力逐渐下降,但耳蜗放大功能完整。总和电位降低,表明内毛细胞(IHC)受体电位发生改变。扫描电子显微镜检查显示 IHC 中的静纤毛束塌陷,而外毛细胞不受影响。此外,在后期阶段,IHC 带状突触发生了结构和功能的改变。使用超分辨率显微镜,我们观察到超大的突触带,并且膜电容测量显示持续可释放池胞吐的释放率增加。这些结果表明,DFNA25 源自机械转导失败,随后发生突触传递改变。VGLUT3 小鼠模型为深入了解和潜在治疗 DFNA25 开辟了道路。关键点: 囊泡谷氨酸转运体 3(VGLUT3)将谷氨酸加载到听觉感觉细胞(内毛细胞,IHC)的突触小泡中。 VGLUT3-p.A211V 变体与人类耳聋 DFNA25 相关。携带 VGLUT3-p.A211V 变体的突变小鼠表现出进行性听力损失。突变小鼠的 IHC 中存在扭曲的静纤毛束,这些静纤毛束检测传入的声音刺激,随后是超大的突触带,将谷氨酸释放到传入神经纤维上。这些结果表明,DFNA25 源自听觉感觉细胞无法将声音刺激准确地转导为神经信号。